COMPOSITIONS AND METHODS FOR USE IN CANCER THERAPY

摘要

Disclosed herein are compositions for co-administering an RTK inhibitor and an RTK ligand. Also disclosed are methods of ameliorating an adverse effect due to the administration of an RTK inhibitor by co-administering an RTK inhibitor and RTK ligand. Also disclosed are methods of informing a subject that co-administration of an RTK inhibitor and an RTK ligand ameliorates an adverse effect due to the administration of an RTK inhibitor.